Responses
Scientific Abstracts
Poster Presentations
Friday, 05 June 2020
Rheumatoid arthritis - non biologic treatment and small molecules
FRI0123 SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 8.4 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS
Compose a Response to This Article
Other responses
No responses have been published for this article.